Pliant Therapeutics PLRX
NASDAQ PLRX
$0.79 -0.01 (-1.74%)
At close: Nov 10, 2026 · 4:00 PM EST

Pliant Therapeutics (PLRX) Other Non-Current Liabilities (2019 - 2021)

Updated

Pliant Therapeutics (PLRX) recorded Other Non-Current Liabilities of $756,000 in Q3 2021, down 20.6% from $952,000 a year earlier and down 6.0% from the prior quarter.

Analysis

Pliant Therapeutics (PLRX) Other Non-Current Liabilities (2019 - 2021) Analysis & Trends

At the end of FY2020, Pliant Therapeutics reported Other Non-Current Liabilities of $866,000, down 5.0% from FY2019.

  • Across earlier years, Other Non-Current Liabilities came in at $912,000 in FY2019.
  • Per Business Quant, the preceding three quarters came in at $804,000 (Q2 2021), $835,000 (Q1 2021) and $866,000 (Q4 2020).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn
10 Pliant Therapeutics 50.15 Mn -711.58 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2021 756,000.00
Jun 30, 2021 804,000.00
Mar 31, 2021 835,000.00
Dec 31, 2020 866,000.00
Sep 30, 2020 952,000.00
Jun 30, 2020 951,000.00
Dec 31, 2019 912,000.00
API Access

Pliant Therapeutics Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=PLRX&period=max&api_key=YOUR_API_KEY